Results 271 to 280 of about 1,226,213 (336)

Use of interferon-gamma release assay (IGRA) and CXCL-10/IP-10 for latent tuberculosis infection (LTBI) screening in chronic kidney disease and hemodialysis patients. [PDF]

BMC Infect Dis
da Silva JCB, Vieira NB, Ribeiro-Alves M, de Almeida Ribeiro RS, da Silva Lemos CC, Mendes R, Gomes CLR, Santos AP, Suassuna JH, Bregman R, Rodrigues LS.   +10 more
europepmc   +1 more source

Interferon gamma-mediated prevention of tumor progression in a mouse model of multiple myeloma. [PDF]

Hemasphere
Kellermayer Z, Tahri S, de Jong MME, Papazian N, Fokkema C, Stoetman ECG, Hoogenboezem R, van Beek G, Sanders MA, Boon L, Den Hollander C, Broijl A, Sonneveld P, Cupedo T.   +13 more
europepmc   +1 more source

Interferon Gamma in Sickness Predisposing to Mycobacterial Infectious Diseases [PDF]

Balkan Med J
Gemici Karaaslan B, Rosain J, Bustamante J, Kıykım A.   +3 more
europepmc   +1 more source

Comparison of Two Interferon-Gamma Release Assays for Pediatric Tuberculosis Infection. [PDF]

J Pediatric Infect Dis Soc
Gaensbauer JT, Reves RR, Katz D, Ahmed A, Venkatappa T.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interferon gamma

Reactions Weekly, 2016
Miriam Wittmann, Martin Stacey
semanticscholar   +4 more sources

Interferon gamma

Reactions Weekly

semanticscholar   +2 more sources